Convergence technology in cancer medicine

References

• von Schulthess GK, Steinert HC, Hany TF. Integrated PET–CT: current applications and future directions. Radiology238, 405–422 (2006).
   PubMed Web of Science ®Google Scholar
• Shmulewitz A, Langer R. The essence of combination products. Nat. Biotechnol.24, 277–280 (2006).
   PubMed Web of Science ®Google Scholar
• Hermann KA, Krause BJ. 18F-labelled PET and PET/CT compounds in oncology. In: Fluorine and Health: Molecular Imaging, Biomedical Materials and Pharmaceuticals. Tressaud A, Haufe G (Eds). Elsevier Science and Technology, Amsterdam, The Netherlands, 141–196 (2008).
   Google Scholar
• Gambhir SS, Czernin J, Schwimmer J et al. A tabulated summary of the FDG–PET literature. J. Nucl. Med.42(5), S1–S93 (2001).
   PubMedGoogle Scholar
• Mettler FA, Milton GJ. Postiron emission tomography (PET) imaging. In: Essentials of Nuclear Medicine (5th Edition). Elsevier, Amsterdam, The Netherlands (2006).
   Google Scholar
• Crernik IF, Dizendorf E, Baumert BG et al. Radiation treatment planning with an integrated positron emission and computed tomography (PET/CT): a feasibility study. Int. J. Radiat. Oncol. Biol. Phys.57, 853–863 (2003).
   PubMed Web of Science ®Google Scholar
• Grosu AL, Molls M, Zimmermann FB et al. High precision radiation therapy with integrated biological imaging and tumor monitoring: evaluation of Munich concept and future research options. Strahlenther. Onkol.182, 361–368 (2006).
   PubMed Web of Science ®Google Scholar
• Klose T, Leidl R, Buchmann I, Brambs HJ, Reske SN. Primary staging of lymphomas: cost effectiveness of FDG–PET versus computed tomography. Eur. J. Nucl. Med.27, 1457–1464 (2000).
   PubMedGoogle Scholar
• Podoloff DA, Ball DW, Ben-Josef E et al. NCCN task force: clinical utility of PET in a variety of tumor types. JNCCN7(2), 1–23 (2009).
   Google Scholar
• Ziznani PL, Stefoni V, Tani M et al. Role of 18F FDG PET scan in the follow up of lymphoma. J. Clin. Oncol.27(11), 1906–1914 (2009).
   PubMed Web of Science ®Google Scholar
• Buck AK, Hermann K, Stargardt T et al. Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches. J. Nucl. Med.51, 401–412 (2010).
   PubMed Web of Science ®Google Scholar
• Roman CD, Martin WH, Delbeke D. Incremental value of fusion imaging with integrated PET–CT in oncology. Clin. Nucl. Med.30, 470–477 (2005).
   PubMed Web of Science ®Google Scholar
• Hillner BE, Siegel BA, Liu D et al. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET registry. J. Clin. Oncol.26, 2155–2161 (2008).
   PubMed Web of Science ®Google Scholar
• Filippi L, Schillaci O. Usefulness of hybrid SPECT-CT in 99mTc-HMPAO-labelled leukocyte scintigraphy for bone and joint infections. J. Nucl. Med.47, 1908–1913 (2006).
   PubMed Web of Science ®Google Scholar
• Ciernik IF, Dizendorf E et al. Radiation treatment planning with an integrated positron emission and computed tomography (PET/CT): a feasibility study. Int. J. Radiat. Biol. Phys.57, 853–863 (2003).
   PubMed Web of Science ®Google Scholar
• Coleman RE, Delbeke D, Guiberteau MJ et al. Intersociety dialogue on concurrent PET–CT with an integrated imaging system: from the joint ACR/SNM/SCBT–MR–PET–CT working group. J. Nucl. Med.46, 1225–1239 (2005).
   PubMed Web of Science ®Google Scholar
• Schreve P. PET/CT. Semin. Ultrasound CT MRI29, 283–289 (2008).
   PubMed Web of Science ®Google Scholar
• Delbeke D, Schoder H, William MH, Wahl RL. Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions. Semin. Nucl. Med.39, 308–340 (2009).
   PubMed Web of Science ®Google Scholar
• Pelosi E, Messa C, Sironi S et al. Value of integrated PET/CT for lesion localization in cancer patients: a comparative study. Eur. J. Nucl. Med. Mol. Imaging31, 932–939 (2004).
   PubMed Web of Science ®Google Scholar
• Fueger BJ, Weber WA, Quon A et al. Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients. Mol. Imag. Biol.7, 369–376 (2005).
   PubMed Web of Science ®Google Scholar
• Tateishi U, Gamez C, Dawood S et al. Bone metastases in patients with metastatic breast cancer: Morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT. Radiology247, 189–196 (2008).
   PubMed Web of Science ®Google Scholar
• Goerres GW, Stupp R, Barghouth G et al. The value of PET, CT, in line PET–CT in patients with gastrointestinal stromal tumors: long term outcome of treatment with imatinib mesylate. Eur. J. Nucl. Med. Mol. Imaging.32, 153–162 (2005).
   PubMed Web of Science ®Google Scholar
• Papathanassiou D, Liehn JC. The growing development of multimodality imaging in oncology. Crit. Rev. Oncol./Hemat.68, 60–65 (2008).
   PubMed Web of Science ®Google Scholar
• Poeppel TD, Krause BJ, Heusner TA et al. PET/CT for the staging and follow-up of patients with malignancies. Eur. J. Radiol.70, 382–392 (2009).
   PubMed Web of Science ®Google Scholar
• Antoch G, Vogt FM, Freudenberg LS et al. Whole body dual modality PET/CT and whole body MRI for tumor imaging in oncology. JAMA290(24), 3199–3206 (2003).
   PubMed Web of Science ®Google Scholar
• Bar-Shalom R, Yefremov N, Guralnik L et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J. Nucl. Med.44(8), 1200–1209 (2003).
   PubMed Web of Science ®Google Scholar
• Lardinios D, Weder W, Hany TF et al. Staging of non small cell lung cancer with integrated positron emission tomography and computed tomography. N. Engl. J. Med.348(25), 2500–2507 (2003).
   PubMed Web of Science ®Google Scholar
• Heron DE, Andrade RS, Beriwal S et al. PET–CT in radiation oncology: the impact of diagnosis, treatment planning and assessment of treatment response. Am. J. Clin. Oncol.31(4), 352–362 (2008).
   PubMed Web of Science ®Google Scholar
• Von Schulthess GK, Steinhart HC, Hany TF et al. Integrated PET/CT: current applications and future directions. Radiology238(2), 405–422 (2006).
   PubMed Web of Science ®Google Scholar
• la Fougere C, Hundt W, Brockel N et al. Value of PET/CT versus PET and CT performed as separate investigations in atients with Hodgkin’s disease and non Hodgkin’s lymphoma. Eur. J. Nucl. Med. Mol. Imaging33(12), 1417–1425 (2006).
   PubMed Web of Science ®Google Scholar
• Hutchings M, Loft A, Hansen M et al. Positron emission tomography with or without computed tomography in the primary staging of Hodgkin’s lymphoma. Haematologica91(4), 482–489 (2006).
   PubMed Web of Science ®Google Scholar
• Romer W, Nomayr A, Uder M et al. SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients. J. Nucl. Med.47, 1102–1106 (2006).
   PubMed Web of Science ®Google Scholar
• Horger M, Eschmann SM, Pfannenberg C et al. Evaluation of combined transmission and emission tomography for classification of skeletal lesions. AJR Am. J. Roentgenol.183, 655–661 (2004).
   PubMed Web of Science ®Google Scholar
• Utsunomiya D, Shiraishi S, Imuta M et al. Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and non scintigraphy and CT. Radiology238, 264–271 (2006).
   PubMed Web of Science ®Google Scholar
• Wilkinson JM. Cultivate technology convergence for product innovation. Med. Device Technol.17(3), 34–36 (2006).
   PubMedGoogle Scholar
• Pirotte B, Goldman S, Van Bogaert P et al. Integration of [11-C] methionine-positron emission tomographic and magnetic resonance imaging for image guided surgical resection of infiltrative low grade brain tumors in children. Neurosurgery57, 128–139 (2005).
   PubMed Web of Science ®Google Scholar
• Pichler BJ, Wehrl HF, Kolb A et al. Positron emission tomography/magnetic resonance imaging: the next generation of multimodality imaging? Semin. Nucl. Med.38, 199–208 (2008).
   PubMed Web of Science ®Google Scholar
• Pandya S, Motkoski JW, Serrano-Almeida C et al. Advancing neurosurgery with image guided robotics. J. Neurosurg.111, 1141–1149 (2009).
   PubMed Web of Science ®Google Scholar
• Webster MW, Ormiston JA. Sorting out drug eluting stents. Lancet375 (9720), 1090–1099 (2010).
   PubMed Web of Science ®Google Scholar
• Willis SL, Lewis AL. The interface of medical devices and pharmaceuticals: part I. Med. Device Technol.19(2), 42–45 (2008).
   PubMedGoogle Scholar
• Willis SL, Lewis AL. The interface of medical devices and pharmaceuticals: part II. Med. Dev. Technol.19 (3), 38–43 (2008).
   PubMedGoogle Scholar
• Portnoy S, Koepke S. Regulatory strategy: preclinical testing of combination products. Med. Dev. Diag. Indust.27(5), 152–158 (2005).
   Google Scholar
• Gonzalez MV, Tang Y, Phillips GJ et al. Doxorubicin eluting beads – 2: methods for evaluating drug elution and in vitro: in vivo correlation. J. Mater. Sci. Mater. Med.19(2), 767–775 (2007).
   PubMed Web of Science ®Google Scholar
• Perry J, Chambers A, Spithoff K et al. Gliadel wafers in the treatment of malignant glioma: a systematic review. Curr Oncol.14(5), 189–194 (2007).
   PubMedGoogle Scholar
• Westphal M, Hilt DC, Bortey E et al. A Phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-Oncology5, 79–88 (2003).
   PubMed Web of Science ®Google Scholar
• Li Y, Ho Duc HL, Tyler B et al.In vivo delivery of BCNU from a MEMS device to a tumor model. J. Control. Release106(1–2), 138–145 (2005).
   PubMed Web of Science ®Google Scholar
• Van De Wiele C, Defreyne L, Peeters M, Lambert B. Yttrium-90 labelled resin microspheres for treatment of primary and secondary malignant liver tumors. J. Nucl. Med. Mol. Imaging53(3), 317–324 (2009).
   PubMed Web of Science ®Google Scholar
• Biocompatibles: Crossing over to the convergence side in cancer and stroke. In Vivo27(3), 1–9 (2009).
   Google Scholar
• Park JH, Maltzahn GV, Xu MJ et al. Cooperative nanomaterial system to sensitize, target, and treat tumors. Proc. Natl Acad. Sci. USA107(3), 981–986 (2010).
   PubMed Web of Science ®Google Scholar
• Castaneda M. Connecting devices and data on the healthcare network. Biomed. Instrum. Technol.44(1), 18–25 (2010).
   PubMedGoogle Scholar
• Moorman B. Interoperability: monitor and ventilator interfaces to health connect. Presented at: KP Northern California Clinical Technology Plan Summit. CA, USA, September 2008.
   Google Scholar